BEIJING (Bloomberg): Chinese researchers have applied for a local patent on an experimental Gilead Sciences Inc drug that they believe might fight the novel coronavirus outbreak.
The Wuhan Institute of Virology -- based in the central Chinese city at the epicentRE of the epidemic -- has applied for a patent in China for the use of the antiviral drug, know as remdesivir, in treating the ailment.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!